Enovis Corp (NYSE: ENOV) on Tuesday, plunged -3.27% from the previous trading day, before settling in for the closing price of $27.2. Within the past 52 weeks, ENOV’s price has moved between $25.47 and $49.38.
Annual sales at Healthcare sector company slipped by -4.65% over the past five years. The company achieved an average annual earnings per share of 12.26%. With a float of $56.05 million, this company’s outstanding shares have now reached $57.19 million.
Let’s look at the performance matrix of the company that is accounted for 7367 employees.
Enovis Corp (ENOV) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Enovis Corp is 1.99%, while institutional ownership is 114.56%. The most recent insider transaction that took place on Dec 09 ’25, was worth 27,176. In this transaction Former EVP, Strategy & Bus Dev of this company sold 999 shares at a rate of $27.20, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 09 ’25, when Company’s Former EVP, Strategy & Bus Dev sold 666 for $27.21, making the entire transaction worth $18,122. This insider now owns 160,449 shares in total.
Enovis Corp (ENOV) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.98 earnings per share (EPS) for the period topping the consensus outlook (set at 0.92) by 0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.26% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.22% during the next five years compared to -4.65% drop over the previous five years of trading.
Enovis Corp (NYSE: ENOV) Trading Performance Indicators
Enovis Corp (ENOV) is currently performing well based on its current performance indicators. A quick ratio of 1.16 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.67. Likewise, its price to free cash flow for the trailing twelve months is 66.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -24.21, a number that is poised to hit 0.82 in the next quarter and is forecasted to reach 3.45 in one year’s time.
Technical Analysis of Enovis Corp (ENOV)
Enovis Corp (NYSE: ENOV) saw its 5-day average volume 0.98 million, a negative change from its year-to-date volume of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 45.02%.
During the past 100 days, Enovis Corp’s (ENOV) raw stochastic average was set at 9.59%, which indicates a significant decrease from 21.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.23 in the past 14 days, which was higher than the 1.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $29.56, while its 200-day Moving Average is $31.61. Nevertheless, the first resistance level for the watch stands at $26.90 in the near term. At $27.48, the stock is likely to face the second major resistance level. The third major resistance level sits at $27.85. If the price goes on to break the first support level at $25.94, it is likely to go to the next support level at $25.57. Assuming the price breaks the second support level, the third support level stands at $24.99.
Enovis Corp (NYSE: ENOV) Key Stats
Market capitalization of the company is 1.50 billion based on 57,189K outstanding shares. Right now, sales total 2,108 M and income totals -825,490 K. The company made 548,910 K in profit during its latest quarter, and -571,150 K in sales during its previous quarter.
